Director, Public Policy

30 Sep, 2020

Jobs

Director, Public Policy

Alexion Pharmaceuticals
Washington, DC

Position Summary

The Director of Public Policy will support Alexion’s US Government Affairs and Policy organization through analysis of public payer issues and trends and positioning Alexion as a leader in rare disease treatment access. Reporting to the Senior Director of Policy and working closely with Global Marketing and US Market Access teams. The director will help support launch strategies and access for Alexion’s pipeline and product portfolio.  

Job Duties and Responsibilities

  • Contribute to Alexion macro level policy strategy for pipeline indications across business units and brands. Provide expertise on issues including but not limited to rare disease and specialty drug access, Medicare and Medicaid payment systems, commercial payer benefit design, drug pricing, and health reform.
  • Propose, design, and execute initiatives that mitigate risks or proactively advance Alexion’s mission to serve patients and families with rare disease.
  • Provide feedback to internal stakeholders and leadership on risks and opportunities in policy landscape; anticipate issues and provide analysis directly relevant to current and future portfolio strategy.
  • Partner with colleagues in Government Affairs, Market Access, Pricing and Value, Patient Advocacy, Patient Services, Medical Affairs and others to align on issues and trends that require policy strategy.

Essential Qualifications

  • 10+ years of experience in health policy with extensive knowledge of federal health programs and public payer policy
  • Should have a strong understanding (expertise) in US coding and reimbursement systems, including the process for applying for HCPCS, CPT, and ICD-10 codes as well as NTAP and Pass-through payment
  • Prior market access experience is highly desirable
  • Excellent verbal, analytical, written, and interpersonal communication skills; emphasis on ability to distill complex information or concepts
  • High attention to detail and demonstrated organizational and project management skills
  • Entrepreneurial, driven, and highly collaborative across matrixed enterprise
  • Impeccable personal character and high integrity

Preferred Qualifications

  • Prior pharmaceutical or device industry experience is preferred
  • Non-profit or patient advocacy experience is welcomed
  • Medicare Part A Inpatient Prospective Payment System policy expertise is highly desired
  • Advanced degree in public policy, health policy, public health, or health economics

*LI-DD1

Washington, DC, United States

Some opportunities happen only once in a lifetime – like a job where you have the extraordinary opportunity to change lives. At Alexion, such opportunities arise through our unwavering mission to serve patients and families affected by rare diseases. These patients are our guiding star, and we act with integrity, urgency, and discipline because we know their lives are at stake.

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies. As the global leader in complement biology and inhibition for more than 20 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) as well as the first and only approved complement inhibitor to treat atypical hemolytic uremic syndrome (aHUS), anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D). In addition, the company is developing several mid-to-late-stage therapies, including a second complement inhibitor, a copper-binding agent for Wilson disease and an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases as well as several early-stage therapies, including one for light chain (AL) amyloidosis and a second anti-FcRn therapy. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, and metabolic disorders. Alexion has been named to the Forbes’ list of the World’s Most Innovative Companies seven years in a row and is headquartered in Boston, Massachusetts’ Innovation District. The company also has offices around the globe and serves patients in more than 50 countries. Further information about Alexion can be found at: www.alexion.com.

As a leading employer in our industry, Alexion is proud to offer a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more.

Learn more here

Job posted: 2020-09-30